Recorded Webinar from September 24, 2020
Historically, ligand binding assays used for pharmacokinetic (PK) studies have been implemented with samples run in duplicate, however with advances in LBA technologies there has been an interest in the adoption of singlet methods for the analysis of samples from PK studies. Here, I highlight a retrospective examination of in-house study data on the Gyrolab establishing feasibility for singlet analysis and follow with a discussion of our experiences regarding the shift to singlet analysis for all non-regulated Gyrolab studies, in particular the advantages of singlet on Gyrolab during the ongoing Coronavirus outbreak towards social distancing and minimizing our in-lab footprint.
Senior Associate Scientist,
If you have problems to view the webinar please contact firstname.lastname@example.org